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TECHNICAL NOTE Open Access
In vitro qualitative and quantitative CT
assessment of iodinated aerosol nasal
deposition using a 3D-printed nasal replica
Thomas Sartoretti1, Manoj Mannil2, Stefan Biendl1, Johannes M. Froehlich1*, Hatem Alkadhi2 and Matthias Zadory1
Abstract
Computed tomography can provide high-resolution details on nasal anatomy being potentially useful for the
assessment of nasal spray deposition. The purpose of this technical note was to present a method based on CT
imaging to assess qualitatively and quantitatively the in vitro spray deposition patterns within the sinonasal cavities
of a nasal replica obtained by three-dimensional (3D) printing, using iodinated contrast agent labelled solutions
with high spatial and temporal resolution. Using a third generation dual-source CT scanner in single energy mode,
scans of a nasal replica were acquired following application of iodinated contrast agent labelled aerosols with an
iodine concentration of 92.5 mgl/mL. Two software programmes were then utilised (Osirix MD v.9.0, Pixmeo,
Geneva, Switzerland; 3mensio, Pie Medical Imaging, Bilthoven, Netherlands) to generate three-dimensional
reconstructions of the scans, thus enabling the rapid detection and visualisation of administered single droplets and
their voxel-by-voxel localisation. Using this approach, we achieved recovery rates between 84–98% and 89–109%
(depending on the software programme) of the total applied aerosol volume.
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Key points
 Computed tomography provides high-resolution de-
tails on nasal anatomy.
 Nasal aerosol deposition patterns can be imaged
with computed tomography using iodinated contrast
media
 Nasal aerosol deposition patterns can be quantified
using a freeware software.
Background
Transmucosal nasal drug delivery by means of nasal
sprays is an option for challenging clinical situations
offering systemic treatment approaches. Specifically,
nasal drug delivery provides numerous advantages
such as easy access, rapid onset of the therapeutic ef-
fect, no first-pass metabolism and potential for direct
nose-to-central nervous system delivery [1–3].
Therefore, precise targeting of certain locations within
the nasal cavity for efficient drug delivery is of inter-
est explaining the decisive importance to better under-
stand and characterise nasal spray deposition patterns.
According to the current understanding, it is variable and
influenced by several factors, specifically the high variabil-
ity of the nasal anatomy between individuals, then by the
patient’s administration technique itself and last but not
least the technical characteristics of the nasal-spray system
such as the plume angles, spray pressure or the colloid
size [1–3]. This warrants the need for a systematic strategy
to assess the nasal deposition characteristics of the
pharmaceutically used devices both qualitatively and
quantitatively with high precision. Moreover, the charac-
terisation technique once validated in vitro should open
up the pathways towards clinical endorsement.
Several nasal spray deposition assessment methods,
both in vivo and in vitro, have been reported [1–5], yet
each method bears substantial limitations such as lack of
simplicity or low clinical suitability. An imaging ap-
proach such as computed tomography (CT) with its high
temporal and spatial resolution and possibly low
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radiation dose may represent a valuable approach as it
enables a fast acquisition of images and is readily avail-
able in various clinical settings [6–11].
The purpose of this study was to develop an in vitro
approach based on CT imaging in combination with an
iodinated contrast agent (ICA)-labelled nasal spray aque-
ous phase to qualitatively and quantitatively assess its
deposition within the sinonasal cavity of a nasal replica.
Methods
ICA-labelled nasal spray
Our approach consisted of applying an ICA aerosol
through a nose spray device into a nasal cavity replica
followed by CT imaging. For the application of the io-
dinated solution, a specific type of unit dose spray device
(Unit Dose, Aptar Pharma, Le Neubourg, France) was
filled and utilised based on the supplier’s specifications,
thus delivering with each puff a volume of 0.065 ± 0.010
mL of the iodinated solution into the nostrils. The
sprays were labelled with a diluted aqueous ICA (Iopa-
midol DCI, Iopamiro, Bracco, Cadempino, Switzerland)
solution with a concentration of 92.5 mgI/mL.
The ideal iodine concentration for optimal image im-
pression was determined by preliminary CT scans of a
dilution series of the IVA ranging from 0 to 370 mgI/mL
iodine concentration using a nasal cavity replica. The
optimal concentration was chosen so that no artefacts
were visible on the CT images, while retaining suitable
contrast for quantification.
Nasal cavity replica
The nasal cavity replica made of synthetic polymer
(epoxy resin) was prepared by means of stereolithog-
raphy based on three-dimensional files of a 33-year-old
female cadaver without nasal disease [12]. The reso-
lution was quoted to be at about 0.15 mm. The material
was chosen as it allows good distinction between the
hyperdensity of ICA deposited droplets and the x-ray
imaging of the anatomical structure of the cast.
The nose of the replica with a special support was
constructed of a flexible polymer (silicone) to allow for
proper placement of the nasal application device. Specific-
ally, the spray device was always placed into a dedicated
support below the nostril to allow for a standardised
application and positioning (45° angle) of the spray
system (Fig. 1a).
CT scan protocol and aerosol application
For all experiments, a third generation dual-source CT
scanner (SOMATOM Force, Siemens Healthineers, For-
chheim, Germany) in single energy mode was utilised.
Scan parameters are shown in Table 1. Initially, an unen-
hanced scan of the nasal replica without application of
the aerosol was performed (native baseline, serving as
internal control) followed by four applications of the
aerosol: two single applications into the left nostril, one
single application into the right nostril, one further appli-
cation on the right side consisting of two single applica-
tions in rapid succession, thus totalling a double-dose. For
each application, the spray device was positioned into one
nostril, secured by the dedicated support, and a puff was
applied by pressing manually the triggering mechanism on
the bottom of the device. The replica was always scanned
in the exact same position simulating the position of the
head of an upright subject. CT scans were acquired on
average 10 ± 3 s after device-controlled application of the
iodinated solution into the nostrils of the replica. After
scanning, the replica was disassembled, washed, and dried
thoroughly followed by a non-enhanced scan before exe-
cution of the next exposition series (Table 2).
CT data post-processing
Post-processing was performed on a personal computer
without dedicated graphics processing unit by two readers
(J.F. 20 years of experience; M.Z., 4 years of experience.).
First, a three-dimensional (3D) reconstruction of CT im-
ages was performed using a freeware postprocessing soft-
ware (Osirix MD v.9.0, Pixmeo, Geneva, Switzerland). An
optimal subjective image quality was achieved by manually
optimising the contrast between hyperdense droplets and
less intense structures of the replica enabling qualitative
assessments (Fig. 1b, c). Second, using two different soft-
ware programmes (Osirix MD v.9.0, Pixmeo, Geneva,
Switzerland; 3mensio, Pie Medical Imaging, Bilthoven,
Netherlands), quantification of the deposition within the
sinonasal cavity of the nasal replica was performed (Fig. 1).
Both programmes allowed for the direct identification of
droplet depositions on the scans performed after the
application of the iodinated solution by using a threshold
approach based on the density values of the voxels,
expressed in Hounsfield units (HU). The total deposition
volume was then calculated fully automatically with a
region-growing algorithm. To determine the accuracy, the
recovery rate was calculated by dividing the measured
volume (region-growing algorithm) through the applied
volume multiplied by 100.
Radiation dose estimation
Radiation dose estimations were taken from the elec-
tronically logged dose protocols which are automatic-
ally generated by the scanner after data acquisition.
The average volume CT dose index (CTDIvol) per
scan was 7.6 mGy.
Results
Qualitative analysis
The iodinated droplets were visible as single speckles
(rather than large clouds) adhering to the underlying
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anatomical structures (Fig. 1). A good contrast between
droplets and cast was achieved because of the large differ-
ences in attenuation between droplets (mean of 3 mea-
surements, 1080 HU) and cast (mean values of 480 HU).
Regarding the spatial distribution in the nasal cavity of
the single nasal spray device applications, we found large
parts of the droplets in the upper and middle nasal me-
atus (Fig. 2). Only very few droplets were visible in the
inferior part of the nasal cavity despite gravitational in-
fluence, and no droplets were visible in distant regions
close to the trachea. No side-dependent difference in the
distribution of the droplets could be observed when
comparing left versus right side application. The depos-
ition patterns between the left and right sides (and be-
tween different scans) were similar.
After the application of the double dose (administered
as two subsequent single doses) into the right nostril,
larger single droplets were visible in the upper nasal me-
atus, a larger number of droplets were visible in the re-
gion near the semilunar hiatus and very few droplets
reached more distal regions of the nasal cavity.
Quantitative analysis
Quantification yielded recovery rates ranging from 83.8 to
98.1% of the total applied volume (0.065mL or 0.13mL)
with OsirixMD and from 89.2 to 109.2% of the total ap-
plied volume (0.065 of 0.13mL) with 3mensio, respectively.
OsirixMD achieved the highest accuracy in quantifying the
deposition pattern of the second single application into the
left nostril (0.0638 of 0.065mL, 98.1%) while 3mensio
Fig. 1 Three-dimensional volume-rendered computed tomography image demonstrating the nasal cast from anteriorly: the nose spray (arrow)
was applied into the support below the right nostril for standardised application of the spray (a). Sagittal reformation depicting the iodinated
contrast agent droplets in the nasal cavity (bright hyperdense spots) (b). The colours indicate pixels with attenuation values exceeding the
predefined threshold in the region of interest (c). On the lower image, a sagittal image after segmentation is shown. The green colour indicates
the iodinated deposited droplets. Note the depositions mainly in regions next to the superior and middle concha
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achieved the highest accuracy in quantifying the de-
position pattern of the single application into the
right nostril (0.061 of 0.065 mL, 93.8%). Detailed re-
sults are provided in Table 2.
Discussion
Our study is the first, to our knowledge, to demonstrate
the feasibility of CT imaging to enable a qualitative and
quantitative assessment of in vitro nasal spray droplet de-
position after nasal administration. This not only promises
to improve characterisation of the various available nasal
spray devices and their deposition patterns, but also opens
up the field for this promising new drug administration
route in the systemic treatment of challenging pathologies.
Based on preliminary CT scans, we found that the qualita-
tive assessment was adequate at iodine concentrations of
80mg/mL and higher. For the quantitative assessment, it
seems that the highest possible concentration without
artefacts should be chosen. At 92.5 mgI/mL iodine con-
centration, a good trade-off was achieved, yielding total re-
covery rates between 84–98% and 89–109%, respectively,
of the total applied aerosol volume depending on the
post-processing software used.
Currently, scintigraphy with a radioactive aerosol is
considered the reference standard for nasal deposition
studies [5]. Several drawbacks such as the rather slow
two-dimensional imaging with a low spatial resolution,
lack of anatomical visualisation, and the use of radio-
active tracers [3, 4] can be overcome with a CT-based
method. Imaging units combining single-photon emis-
sion computed tomography and CT provide improved
resolution and high sensitivity, offering the opportunity
to visualise the underlying anatomical structures [4], but
still suffers from long imaging times and the need of ad-
ministering a radioactive tracer such as 99mTc (400MBq
of DTPA-Technetium 99m (99mTc) solution suffices to
map the aerosol deposition using the combined single-
photon emission computed tomography and CT ap-
proach described by Leclerc et al. [4]).
We showed here that a pure CT-based imaging tech-
nique using an ICA labelling allows for rapid detection
of administered single droplets and their voxel-by-voxel
localisation, potentially overcoming those drawbacks of
the current reference standard from nuclide imaging. In-
stead of deposition patterns provided by using radio-
active tracers resembling intranasal clouds, our method
enables visualisation of single droplets before the deposi-
tions aggregate into larger speckles under gravitational
influence. This might be explained by keeping the dur-
ation between aerosol application and image acquisition
short (10 s). Moreover, our method using a low dose
clinical CT protocol (CTDIvol 7.6 mGy) can most prob-
ably be easily transferred to a clinical setting.
We envisage the future use of this method in a per-
sonalised medicine setting, where nasal drug delivery
is tailored to the needs of individual patients and
more precise dose regimens are aimed for. Specific-
ally, this approach could be used to determine the
optimal application angle of nasal sprays for individ-
ual patients taking into account certain anatomical
configurations of the nasal cavity, which would enable
optimal drug delivery to specified locations. The sys-
temic availability of the applied drugs and precise
dosing highly depend on the deposition patterns
emphasising the importance of this method. More-
over, this could be of interest also for patients with
neurological disorders relying on medication that can
pass directly from the upper nasal cavity to the cen-
tral nervous system via the olfactory regions.
Table 2 Overview of the volumetric quantification and recovery rates of the nasal droplet depositions after nasal application of an
iodinated contrast agent solution with 92.5 mgI/mL using a single-dose nasal spray device
Application Applied volume of
iodinated aerosol (cm3)
Volume quantified
using OsirixMD (cm3)
Volume quantified
using 3mensio (cm3)
Recovery rate (%)
(OsirixMD; 3mensio)
1 0.065 0.0595 0.058 91.5; 89.2
2 0.065 0.0638 0.071 98.1; 109.2
3 0.065 0.0545 0.061 83.8; 93.8
4 0.130 0.1090 0.118 83.8; 90.7
Table 1 Scan protocol and reconstruction parameters using a
dual-source computed tomography scanner
Parameters Values
Tube voltage (kVp) 90
Tube current (mAs) 67–98*
Spiral pitch factor 0.7
Scan time (s) 6.8
CTDIvol (mGy) 7.6
Slice thickness (mm) 0.75
Increment (mm) 0.5
Field of view (mm) 350 × 1200
Matrix size 512 × 512
Pixel size (mm) 0.488 × 0.488
Scan orientation Coronal
CTDIvol volume computed tomography dose index. The unit was a Somatom
Force, Siemens Healthineers, Forchheim, Germany
*Attenuation-based tube current modulation
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There are several limitations to our study that have to
be acknowledged. In the CT scan protocol (designed for
clinical use), a slice thickness of 0.75mm with 0.5 mm in-
crement was chosen. We assume that resolution and other
protocol parameters may significantly influence the quan-
tification process and its accuracy. Despite achieving high
recovery rates, it needs to be emphasised that it is too
early to estimate the overall accuracy and reliability of our
quantification methods. The differences in recovery rates
observed between the two software programmes may
stem from different algorithms and thresholding ap-
proaches. Specifically, partial volume effects may explain
why we observed recovery rates greater than 100%. Voxels
containing even miniature amounts of iodine still exhibit
high average HU values due to the large difference in
density between iodine and air (or the cast material).
Thus, even slight thresholding differences between the
two software programmes may lead to the inclusion or ex-
clusion of vast amounts of voxels containing very little
amounts of iodine. In case of recovery rates greater than
100%, the algorithm probably overestimated the amount
of iodine by selecting a slightly lower threshold than the
other software programme.
We chose two established and simple-to-use freeware
software programmes for quantification, yet other software
solutions may yield different results. These factors besides
the use of other nasal replicas should be examined system-
atically in future studies. Furthermore, when utilising this
method to accurately characterise deposition patterns of in-
dividuals in future studies, inspiration through the nose
should probably be included into the simulation eventually
using a vacuum [13] as this may significantly impact the de-
position pattern. Further quantification methods allowing
better differentiation of materials including dual-energy CT
techniques should be investigated.
In conclusion, the present in vitro study indicates that
CT-based imaging allows for a qualitative and quantitative
assessment of the distribution of ICA-labelled nasal spray
solutions administered into the nasal cavity with both high
spatial and temporal resolution.
Fig. 2 Coronal projection diagram of the distribution of droplets within the nasal cavity. The left side shows the distribution pattern after nasal
application of the double dose (two single applications in rapid succession) while the right sides represent a single dose application. The distribution
of droplets from different coronal slices (including both single and double dose scans) was projected onto a single coronal slice. Droplets are indicated
as dark spots. The droplets’ size is an accurate representation of their relative size in comparison to the underlying anatomical structures. Note the
presence of droplets predominantly in the superior and middle nasal meatus and for the double dose in the regions of the semilunar hiatus
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